Solvonis Therapeutics PLC (SVNS) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Dec 2025 07:00 AM
RNS
SVN-015 accepted into US NIDA funded programme
31 Oct 2025 03:59 PM
RNS
Total Voting Rights
31 Oct 2025 07:00 AM
RNS
Corporate Structure Update and Issue of Options
27 Oct 2025 07:00 AM
RNS
Appoints global biopharma leader Paul Carter
16 Oct 2025 07:00 AM
RNS
Raises £1.25 Million to Accelerate Programmes
30 Sep 2025 07:00 AM
RNS
Half-year Report
28 Aug 2025 07:00 AM
RNS
Solvonis secures exclusive CNS collaboration
13 Aug 2025 03:03 PM
RNS
Media Coverage: Small Cap Idea profile
12 Aug 2025 07:00 AM
RNS
SVN-SDN-14 PTSD - Positive pre-clinical results
31 Jul 2025 04:30 PM
RNS
Total Voting Rights
22 Jul 2025 07:00 AM
RNS
Translational Bridging Studies
18 Jul 2025 11:03 AM
RNS
Exercise of warrants
14 Jul 2025 07:00 AM
RNS
Solvonis Chair to speak at Lucid Capital Markets
11 Jul 2025 07:00 AM
RNS
£1m subscription to accelerate AI drug discovery
08 Jul 2025 07:00 AM
RNS
Holding(s) in Company
27 Jun 2025 02:38 PM
RNS
AGM Statement
27 Jun 2025 08:54 AM
RNS
Holding(s) in Company
26 Jun 2025 10:21 AM
RNS
Initiation of Research Coverage
23 Jun 2025 07:00 AM
RNS
Allowance of U.S. patent covering AI-supported CNS
11 Jun 2025 07:30 AM
RNS
Initiation of AI supported CNS drug discovery
05 Jun 2025 07:00 AM
RNS
Synthesis of development candidate for SVN-SDN-014
03 Jun 2025 04:30 PM
RNS
Notice of Annual General Meeting
03 Jun 2025 07:00 AM
RNS
Appointment of Prof. David Nutt as CSO
02 Jun 2025 11:58 AM
RNS
Holding(s) in Company
30 May 2025 05:00 PM
RNS
Total Voting Rights
29 May 2025 03:11 PM
RNS
Holding(s) in Company
29 May 2025 12:02 PM
RNS
Holding(s) in Company
29 May 2025 10:30 AM
RNS
Holding(s) in Company
29 May 2025 07:00 AM
RNS
Presentation at Mello2025
28 May 2025 07:30 AM
RNS
Holding(s) in Company
28 May 2025 07:00 AM
RNS
Completion of the acquisition of Awakn
21 May 2025 03:24 PM
RNS
Publication of a Prospectus
16 May 2025 07:31 AM
RNS
Result of placing
15 May 2025 04:53 PM
RNS
Proposed equity fundraising via ABB
28 Apr 2025 11:30 AM
RNS
Result of General Meeting
23 Apr 2025 07:00 AM
RNS
Proposed acquisition of Awakn approved
16 Apr 2025 07:00 AM
RNS
Final Results for the year ended 31 December 2024
10 Apr 2025 02:00 PM
RNS
Posting of Circular and Notice of General Meeting
07 Apr 2025 07:00 AM
RNS
Holding(s) in Company
04 Apr 2025 07:00 AM
RNS
Engagement of PharmaVentures
26 Mar 2025 07:00 AM
RNS
Positive progress on European Patent Application
18 Mar 2025 07:00 AM
RNS
Update on AWKN-SDN-14 programme
11 Mar 2025 09:00 AM
RNS
Holding(s) in Company
11 Mar 2025 07:00 AM
RNS
Appointment of Non-Executive Director
25 Feb 2025 07:00 AM
RNS
Presentation at PharmaSynergyRx Event
24 Feb 2025 07:00 AM
RNS
Entry into an Arrangement Agreement with Awakn
30 Jan 2025 12:00 PM
RNS
Proactive Investors interview with Chairman
27 Jan 2025 07:00 AM
RNS
Update on Awakn Life Sciences’ R&D Progress
24 Jan 2025 07:00 AM
RNS
Investor Presentation
21 Jan 2025 02:29 PM
RNS
Proactive Investors interview with CEO
UK 100

Latest directors dealings